Skip to main content Skip to footer


In brief


of individuals use virtual consultations vs 6% pre-pandemic.


use electronic health records vs 4% pre-pandemic.

Varying needs, common expectations


want a medical provider who explains their condition and treatment clearly.


want a medical provider who listens to their needs and offers emotional support.


want well-coordinated care and communications.


want efficient medical visits.

Address the data dilemma


said the pandemic made them consider that they should have the right to approve the collection and use of their personal health information (PHI) for any purpose beyond their treatment.

Enable healthcare providers to become digital advocates


of respondent’s trust information provided by their traditional healthcare providers such as doctors and hospitals.


of UK respondents said they would be uncomfortable using digital technology and AI to get a diagnosis, treatment or take part in clinical trial.

Build a new relationship between pharmaceutical companies and patients


of people want transparency in research and development.


want clearer communication about medications/treatments effectiveness and their side effects.


say lack of awareness stops them participating in clinical trials.

The time is right for next-generation healthcare experiences

Ashish Goel

Senior Managing Director – Health Lead, Europe

Ashish is the lead for Accenture’s health business in the UK and is deeply passionate about the power of technology and digital in transforming healthcare and wellbeing.

Jean Liao

Managing Director – Life Sciences


Pervaise Khan

Managing Director – Life Sciences UKI Industry Lead

Daniel Owczarski

Global Health Research Lead

Selen Karaca-Griffin

Senior Principal – Research, Life Sciences, Global

Related capabilities

Health experience

Keeping people at the core with insights, technologies and programmes.

Patient services

Helping you improve patient care and health outcomes with innovative services.

Precision medicine

Realising data-driven, personalised care to treat patients based on their unique genomic characteristics.